Lisdexamfetamine, marketed as Vyvanse, is a prescription medication approved for attention deficit hyperactivity disorder in children and adults . In Canada, its distribution is strictly regulated by Health https://buy-sandoz-lisdexamfetam240350.polarisnewsblog.com/552315/lisdexamfetamine-in-canada-a-detailed-guide